Cargando…
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections
INTRODUCTION: Antifungal prophylaxis in patients at high risk for invasive fungal infections (IFIs), such as those with acute myeloid leukemia or myelodysplastic syndromes, continues to be underused in Asia, despite the fact that it reduces IFI-related death and increases IFI-free survival. We chara...
Autores principales: | Wu, Depei, Mi, Yingchang, Weng, Jianyu, Zhuang, Junling, Ke, Xiaoyan, Wang, Chun, Liu, Kaiyan, Martinho, Monika, Winchell, Gregory A., Zang, Yanqiao, Xu, Lianzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989837/ https://www.ncbi.nlm.nih.gov/pubmed/35167031 http://dx.doi.org/10.1007/s12325-021-02012-1 |
Ejemplares similares
-
Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018) -
1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia
por: Winchell, Gregory A, et al.
Publicado: (2019) -
Safety, Tolerability, and Pharmacokinetics (PK) of Posaconazole (POS) Intravenous (IV) Solution and Oral Powder for Suspension in Children With Neutropenia
por: Groll, Andreas H, et al.
Publicado: (2017) -
Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016) -
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
por: Allegra, Sarah, et al.
Publicado: (2017)